Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure

Pulmonary Circulation

Volumn 3, Issue 4, 2013, Pages 916-925

  Heresi, Gustavo A ^a   Minai, Omar A ^a   Tonelli, Adriano R ^a   Hammel, Jeffrey P ^a   Farha, Samar ^a   Parambil, Joseph G ^a   Dweik, Raed A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Pulmonary artery pressure; Pulmonary heart disease; Pulmonary hypertension; Survival

Indexed keywords

EID: 84980597669     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/674756     Document Type: Article

References (23)

1. Batal O, Khatib OF, Bair N, Aboussouan LS, Minai OA. Sleep quality, depression, and quality of life in patients with pulmonary hypertension. Lung 2011;189(2):141-149.
2. Copher R, Cerulli A, Watkins A, Monsalvo ML. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States. J Med Econ 2012;15(5):947-955.
3. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115 (5):343-349.
4. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122(2):156-163.
5. Galiè N, Palazzini M, Manes A. Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. Eur Respir J 2010;36(5):986-990.
6. Hatano S, Strasser T. Primary pulmonary hypertension: report on a WHO Meeting, Geneva, 15-17 October 1973. Geneva: World Health Organization, 1975.
7. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(suppl. 1):S55-S66.
8. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34(4):888-894.
9. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(suppl. 1):S43-S54.
10. Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010;182(2):252-260.
11. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
12. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines. http://www.mayo.edu/hsr/techrpt/61.pdf. Published September 3, 1997.
13. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;166(3): 314-322.
14. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients. Chest 1996;109(2):380-386.
15. Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C, Domsic R, et al. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline meanpulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis 2012;71(8): 1335-1342.
16. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009;53(13):1119-1126.
17. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36(10):752-758.
18. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, Mishima M, Kitaichi M, Izumi T. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131(3):650-656.
19. Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG. Borderline mean pulmonary artery pressure in systemic sclerosis patients: trans-pulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 2013; 65 (4):1074-1084.
20. Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Troster N, Hesse C, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009;180(9):881-886.
21. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation 2008;118(21):2183-2189.
22. Whyte K, Hoette S, Herve P, Montani D, Jais X, Parent F, Savale L, et al. The association between resting and mildto-moderate exercise pulmonary artery pressure. Eur Respir J 2012;39(2):313-318.
23. Saggar R, Khanna D, Furst DE, Shapiro S, Maranian P, Belperio JA, Chauhan N, et al. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 2010;62(12):3741-3750.